Showing results (381-390 of 756) with videos related to

Sort By:
Pageof 76
Annals of Hematology|May 1, 1991
Disseminated intravascular coagulation and decrease in fibrinogen levels induced by vincristine/prednisolone therapy of lymphoid blast crisis of chronic myeloid leukemiaG Sunder-Plassmann, W Speiser, C Korninger, et al.
Thrombosis and Haemostasis|June 30, 1989
Thromboxane A2 and prostacyclin generation in the microvasculature of patients with atherosclerosis--effect of low-dose aspirinP A Kyrle, E Minar, B Brenner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1990
IL-3 promotes basophilic differentiation of KU812 cells through high affinity binding sitesP Valent, J Besemer, K Kishi, et al.
Annals of Hematology|October 1, 1995
Rapid elimination of a high-titer spontaneous factor V antibody by extracorporeal antibody-based immunoadsorption and immunosuppressionB Tribl, P Knöbl, K Derfler, et al.
The Journal of Biological Chemistry|June 25, 1992
Characterization of prostaglandin (PG)-binding sites expressed on human basophils. Evidence for a prostaglandin E1, I2, and a D2 receptorI Virgolini, S Li, C Sillaber, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1992
Hereditary deficiency of antithrombin III, protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for rational patient screeningI Pabinger, S Brücker, P A Kyrle, et al.
Haemostasis|January 1, 1981
Plasma concentration of platelet-specific proteins and fibrinopeptide A in patients with artificial heart valvesR Dudczak, H Niessner, E Thaler, et al.
Blut|May 1, 1987
Pregnancy and delivery after bone marrow transplantation (BMT) for severe aplastic anemia (SAA). A case reportM Hinterberger-Fischer, W Hinterberger, A Hayek-Rosenmayr, et al.
British Journal of Haematology|May 1, 1988
IIB von Willebrand's disease: pathogenetic and therapeutic studiesP A Kyrle, H Niessner, J Dent, et al.
Thrombosis and Haemostasis|April 1, 1997
Inhibition rather than enhancement of hemostatic system activation during initiation of oral anticoagulant treatmentP A Kyrle, J Brockmeier, A Weltermann, et al.
Pageof 76